English

Kumamoto University | HIV drug lenacapavir found to disrupt virus formation, creating giant non-infectious particles

Kumamoto University HIV

Joint Japanese research reveals a second mechanism behind the drug’s powerful antiviral activity, offering new insights for developing next-generation HIV treatments. Are you part of a community affected by HIV/AIDS and co-infections?

Lenacapavir is a powerful, long-acting drug used to prevent and treat HIV infection.

Related Articles

زر الذهاب إلى الأعلى